Cleared Abbreviated

K002530 - WELCH ALLYN SPOT CHECK DEVICE

K002530 is an FDA 510(k) clearance for WELCH ALLYN SPOT CHECK DEVICE, manufactured by Welch Allyn, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Abbreviated 510(k) pathway after a 90-day FDA review.

K002530 · Welch Allyn, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
90d
Days
Class 2
Risk

K002530 is an FDA 510(k) clearance for the WELCH ALLYN SPOT CHECK DEVICE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Arden, US). The FDA issued a Cleared decision on November 14, 2000 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

FDA 510(k) Submission Details - K002530

510(k) Number K002530 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 2000
Decision Date November 14, 2000
Days to Decision 90 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 125d · This submission: 90d
Pathway characteristics
Standards-based clearance path.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1207
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K002530.
NONINVASIVE BLOOD PRESSURE MEASUREMENT SYSTEM
K002791 · Unix Electronic Co. , Ltd. · Jan 2001
AMBULATORY BLOOD PRESSURE MONITORING SYSTEM, MODEL SE-25M/25P
K003711 · Sein Electronics Co., Ltd. · Dec 2000
MODEL WS-500 DIGITAL WRIST BLOOD PRESSURE MONITOR
K003444 · Nihon Seimitsu Sokki Co., Ltd. · Nov 2000
CVPROFILOR D0-2020 CARDIOVASCULAR PROFILING SYSTEM
K001948 · Hypertension Diagnostics, Inc. · Nov 2000
FULL AUTO BLOOD PRESSURE MONITOR, MODEL SE-7700H
K003282 · Sein Electronics Co., Ltd. · Nov 2000
OSCAR 2, MODEL 222
K003004 · Suntech Medical Instruments, Inc. · Oct 2000
K002530 · WELCH ALLYN SPOT CHECK DEVICE
Download PDF FDA Summary Welch Allyn, Inc.